FY2016 EPS Estimates for Surgery Partners Inc. Increased by KeyCorp (SGRY)
Surgery Partners Inc. (NASDAQ:SGRY) – Stock analysts at KeyCorp raised their FY2016 earnings per share (EPS) estimates for Surgery Partners in a research note issued on Friday. KeyCorp analyst J. Gurda now anticipates that the brokerage will earn $0.68 per share for the year, up from their previous forecast of $0.65. KeyCorp also issued estimates for Surgery Partners’ Q4 2016 earnings at $0.21 EPS, FY2017 earnings at $0.93 EPS and FY2018 earnings at $1.23 EPS.
Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings results on Wednesday, November 9th. The company reported $0.21 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.14 by $0.07. Surgery Partners had a return on equity of 17.09% and a net margin of 2.60%. The company had revenue of $282.70 million for the quarter, compared to analysts’ expectations of $283.80 million. During the same period in the previous year, the business posted $0.04 earnings per share. The business’s quarterly revenue was up 18.0% compared to the same quarter last year.
Other analysts have also recently issued research reports about the company. Zacks Investment Research cut Surgery Partners from a “buy” rating to a “hold” rating in a report on Tuesday. Jefferies Group reissued a “buy” rating and set a $24.00 price objective (down previously from $27.00) on shares of Surgery Partners in a report on Thursday, November 10th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $21.14.
Shares of Surgery Partners (NASDAQ:SGRY) opened at 15.55 on Monday. The company has a 50-day moving average price of $18.29 and a 200 day moving average price of $17.28. The company has a market capitalization of $746.70 million and a PE ratio of 80.15. Surgery Partners has a one year low of $11.76 and a one year high of $22.32.
Several hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. boosted its stake in Surgery Partners by 3.8% in the first quarter. BlackRock Inc. now owns 17,116 shares of the company’s stock valued at $227,000 after buying an additional 632 shares during the last quarter. Bellevue Group AG acquired a new stake in Surgery Partners during the first quarter valued at $133,000. Stonerise Capital Management LLC acquired a new stake in Surgery Partners during the first quarter valued at $5,304,000. Essex Investment Management Co. LLC acquired a new stake in Surgery Partners during the second quarter valued at $409,000. Finally, Bank of New York Mellon Corp boosted its stake in Surgery Partners by 45.0% in the second quarter. Bank of New York Mellon Corp now owns 72,605 shares of the company’s stock valued at $1,300,000 after buying an additional 22,540 shares during the last quarter. 38.34% of the stock is currently owned by hedge funds and other institutional investors.
In other Surgery Partners news, VP Jennifer Baldock sold 2,500 shares of the firm’s stock in a transaction dated Monday, August 29th. The stock was sold at an average price of $19.20, for a total value of $48,000.00. Following the sale, the vice president now owns 66,983 shares of the company’s stock, valued at approximately $1,286,073.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 7.10% of the stock is owned by company insiders.
About Surgery Partners
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Receive News & Stock Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related stocks with our FREE daily email newsletter.